GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » YoY EBITDA Growth

Icon (ICLR) YoY EBITDA Growth : 19.37% (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Icon YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Icon's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 19.37%.

Icon's EBITDA per Share for the three months ended in Mar. 2024 was $5.25.

Icon YoY EBITDA Growth Historical Data

The historical data trend for Icon's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon YoY EBITDA Growth Chart

Icon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.05 -6.45 2.87 83.56 12.65

Icon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.40 9.97 5.73 19.85 19.37

Icon YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Icon's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(18.393-16.328)/ | 16.328 |
=12.65 %

Icon's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(5.245-4.394)/ | 4.394 |
=19.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icon YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Icon's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Icon (ICLR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » YoY EBITDA Growth
Comparable Companies
MTD ILMN WAT LH DGX CRL RVTY A EXAS MEDP TSE:2309 TMO DHR IQV IDXX XSWX:LONN SHSE:603259 XPAR:BIM XPAR:ERF NTRA
Traded in Other Exchanges
ICLR:Mexico IJF:Germany
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Website
https://www.iconplc.com
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.